BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rappaport JA, Waldman SA. The Guanylate Cyclase C-cGMP Signaling Axis Opposes Intestinal Epithelial Injury and Neoplasia. Front Oncol. 2018;8:299. [PMID: 30131940 DOI: 10.3389/fonc.2018.00299] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Cheng W, Pang H, Campen MJ, Zhang J, Li Y, Gao J, Ren D, Ji X, Rothman N, Lan Q, Zheng Y, Leng S, Hu Z, Tang J. Circulatory metabolites trigger ex vivo arterial endothelial cell dysfunction in population chronically exposed to diesel exhaust. Part Fibre Toxicol 2022;19:20. [PMID: 35313899 DOI: 10.1186/s12989-022-00463-0] [Reference Citation Analysis]
2 Sunuwar L, Yin J, Kasendra M, Karalis K, Kaper J, Fleckenstein J, Donowitz M. Mechanical Stimuli Affect Escherichia coli Heat-Stable Enterotoxin-Cyclic GMP Signaling in a Human Enteroid Intestine-Chip Model. Infect Immun 2020;88:e00866-19. [PMID: 31818966 DOI: 10.1128/IAI.00866-19] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
3 Cabri W, Cantelmi P, Corbisiero D, Fantoni T, Ferrazzano L, Martelli G, Mattellone A, Tolomelli A. Therapeutic Peptides Targeting PPI in Clinical Development: Overview, Mechanism of Action and Perspectives. Front Mol Biosci 2021;8:697586. [PMID: 34195230 DOI: 10.3389/fmolb.2021.697586] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Flickinger JC Jr, Rappaport JA, Barton JR, Baybutt TR, Pattison AM, Snook AE, Waldman SA. Guanylyl cyclase C as a biomarker for immunotherapies for the treatment of gastrointestinal malignancies. Biomark Med 2021;15:201-17. [PMID: 33470843 DOI: 10.2217/bmm-2020-0359] [Reference Citation Analysis]
5 Caspi A, Entezari AA, Crutcher M, Snook AE, Waldman SA. Guanylyl cyclase C as a diagnostic and therapeutic target in colorectal cancer. Per Med 2022. [PMID: 35920071 DOI: 10.2217/pme-2022-0026] [Reference Citation Analysis]
6 Mónica FZ, De Nucci G. Tadalafil for the treatment of benign prostatic hyperplasia. Expert Opin Pharmacother 2019;20:929-37. [PMID: 30901259 DOI: 10.1080/14656566.2019.1589452] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
7 Ma M, Li L, Chen H, Feng Y. Oxytocin Inhibition of Metastatic Colorectal Cancer by Suppressing the Expression of Fibroblast Activation Protein-α. Front Neurosci 2019;13:1317. [PMID: 31920487 DOI: 10.3389/fnins.2019.01317] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
8 Freihat LA, Wheeler JI, Wong A, Turek I, Manallack DT, Irving HR. IRAK3 modulates downstream innate immune signalling through its guanylate cyclase activity. Sci Rep 2019;9:15468. [PMID: 31664109 DOI: 10.1038/s41598-019-51913-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
9 Xing C, Zhang T, Liu X, Li C, Yang G, Zhang H, Wang R, Wang K, Miao Y, Lan D. Guanylin ligand protects the intestinal immune barrier by activating the guanylate cyclase-C signaling pathway. Acta Histochem 2022;124:151811. [PMID: 34920371 DOI: 10.1016/j.acthis.2021.151811] [Reference Citation Analysis]
10 Bassotti G, Usai Satta P, Bellini M. Plecanatide for the treatment of chronic idiopathic constipation in adult patients. Expert Rev Clin Pharmacol 2019;12:1019-26. [PMID: 31575291 DOI: 10.1080/17512433.2019.1670057] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
11 Lisby AN, Flickinger JC Jr, Bashir B, Weindorfer M, Shelukar S, Crutcher M, Snook AE, Waldman SA. GUCY2C as a biomarker to target precision therapies for patients with colorectal cancer. Expert Rev Precis Med Drug Dev 2021;6:117-29. [PMID: 34027103 DOI: 10.1080/23808993.2021.1876518] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Busslinger GA, Weusten BLA, Bogte A, Begthel H, Brosens LAA, Clevers H. Human gastrointestinal epithelia of the esophagus, stomach, and duodenum resolved at single-cell resolution. Cell Rep 2021;34:108819. [PMID: 33691112 DOI: 10.1016/j.celrep.2021.108819] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
13 Hofmann F. The cGMP system: components and function. Biol Chem 2020;401:447-69. [PMID: 31747372 DOI: 10.1515/hsz-2019-0386] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
14 Cosma GL, Lobby JL, Fay EJ, Siciliano NA, Langlois RA, Eisenlohr LC. Kinetically distinct processing pathways diversify the CD8+ T cell response to a single viral epitope. Proc Natl Acad Sci U S A 2020;117:19399-407. [PMID: 32719124 DOI: 10.1073/pnas.2004372117] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Gupta N, Choudhary SK, Bhagat N, Karthikeyan M, Chaturvedi A. In Silico Prediction, Molecular Docking and Dynamics Studies of Steroidal Alkaloids of Holarrhena pubescens Wall. ex G. Don to Guanylyl Cyclase C: Implications in Designing of Novel Antidiarrheal Therapeutic Strategies. Molecules 2021;26:4147. [PMID: 34299422 DOI: 10.3390/molecules26144147] [Reference Citation Analysis]
16 Cui WQ, Wang ST, Pan D, Chang B, Sang LX. Caffeine and its main targets of colorectal cancer. World J Gastrointest Oncol 2020; 12(2): 149-172 [PMID: 32104547 DOI: 10.4251/wjgo.v12.i2.149] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
17 Takita H, Darwich AS, Ahmad A, Rostami-Hodjegan A. Application of the Nested Enzyme-Within-Enterocyte (NEWE) Turnover Model for Predicting the Time Course of Pharmacodynamic Effects. CPT Pharmacometrics Syst Pharmacol 2020;9:617-27. [PMID: 32989926 DOI: 10.1002/psp4.12557] [Reference Citation Analysis]
18 Rappaport JA, Waldman SA. An update on guanylyl cyclase C in the diagnosis, chemoprevention, and treatment of colorectal cancer. Expert Rev Clin Pharmacol 2020;13:1125-37. [PMID: 32945718 DOI: 10.1080/17512433.2020.1826304] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
19 Ahmed M, Ahmed S. Functional, Diagnostic and Therapeutic Aspects of Gastrointestinal Hormones. Gastroenterology Res 2019;12:233-44. [PMID: 31636773 DOI: 10.14740/gr1219] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
20 Bouzo BL, Lores S, Jatal R, Alijas S, Alonso MJ, Conejos-Sánchez I, de la Fuente M. Sphingomyelin nanosystems loaded with uroguanylin and etoposide for treating metastatic colorectal cancer. Sci Rep 2021;11:17213. [PMID: 34446776 DOI: 10.1038/s41598-021-96578-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Jiang L, Feng JG, Wang G, Zhu YP, Ju HX, Li DC, Liu Y. Circulating guanylyl cyclase C (GCC) mRNA is a reliable metastatic predictor and prognostic index of colorectal cancer. Transl Cancer Res 2020;9:1843-50. [PMID: 35117531 DOI: 10.21037/tcr.2020.02.34] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
22 Zhang Y, Chiu YL, Chen CJ, Ho YY, Shinzato C, Shikina S, Chang CF. Discovery of a receptor guanylate cyclase expressed in the sperm flagella of stony corals. Sci Rep 2019;9:14652. [PMID: 31601940 DOI: 10.1038/s41598-019-51224-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.7] [Reference Citation Analysis]